New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Dermata Therapeutics, Inc.
DRMAW
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

2M

Biotechnology

0.01USD
0.00 ( 0.00%)
favorite-chart

Relative Strenght

3
favorite-chart

Volume Buzz

100%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

-5%

Quote Panel

Shape
Updated October 12, 2024
1W -4.55 % 1M -16.00 % 3M -57.36 % 1Y -40.43 %

Key Metrics

Shape
  • Market Cap

    2.17M


  • Shares Outstanding

    233.07M


  • Share in Float


  • Dividende

    0


  • Earning Date

    No Data


  • Price Target

    0.0088


  • Average Volume


  • Beta

    0.778


  • Range

    0.0084-0.0084


  • Industry

    Biotechnology


  • Website

    http://www.dermatarx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.00x

P/S Ratio

0.28x

P/B Ratio

0.0

Debt/Equity

0.0%

Net Margin

$-2.2

EPS

How DRMAW compares to sector?

P/E Ratio

Relative Strength

Shape

DRMAW

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

NA
vs NA

Q2.22

arrow
arrow

N/A

NA
vs NA

Q3.22

arrow
arrow

N/A

NA
vs NA

Q4.22

arrow
arrow

N/A

-0.13
vs NA

Q1.23

arrow
arrow

N/A

NA
vs NA

Q2.23

arrow
arrow

N/A

-1.73
vs NA

Q3.23

arrow
arrow

N/A

-0.54
vs NA

Q4.23

arrow
arrow

N/A

NA
vs -0.13

Q1.24

arrow
arrow

N/A

NA
vs NA

Q2.24

arrow
arrow

N/A

NA
vs -1.73

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-32%

-0.32
vs -0.28

Q4.22

arrow
arrow

-26%

-0.26
vs -0.32

Q1.23

arrow
arrow

-27%

-0.27
vs -0.26

Q2.23

arrow
arrow

-21%

-0.21
vs -0.27

Q3.23

arrow
arrow

-27%

-0.27
vs -0.21

Q4.23

arrow
arrow

-34%

-0.34
vs -0.27

Q1.24

arrow
arrow

-82%

-0.82
vs -0.34

Q2.24

arrow
arrow

-85%

-0.85
vs -0.82

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

5

5
vs 4

25%

Q4.22

arrow
arrow

5

5
vs 5

NA

Q1.23

arrow
arrow

5

5
vs 5

NA

Q2.23

arrow
arrow

3

3
vs 5

-40%

Q3.23

arrow
arrow

4

4
vs 3

33%

Q4.23

arrow
arrow

4

4
vs 4

NA

Q1.24

arrow
arrow

5

5
vs 4

25%

Q2.24

arrow
arrow

4

4
vs 5

-20%

Earnings Growth

Latest News